...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >STANDARDIZATION OF A POLYHERBAL PREPARATION (POL–6) FOR TREATMENT OF OXIDATIVE, INFLAMMATORY AND IMMUNE DISORDERS
【24h】

STANDARDIZATION OF A POLYHERBAL PREPARATION (POL–6) FOR TREATMENT OF OXIDATIVE, INFLAMMATORY AND IMMUNE DISORDERS

机译:用于治疗氧化性,炎症性和免疫性疾病的多羟基制剂(POL-6)的标准化

获取原文
           

摘要

Objective: The objective of this study was to develop and standardize a polyherbal preparation (POL–6) and evaluate its use in treating oxidative, inflammatory and immune disorders. Methods: The individual hydroalcoholic extractions of Hypericum perforatum, Bacopa monnieri, Centella asiatica, Withania somnifera, Ocimum sanctum and Camellia sinesis dried plant materials were done, and POL–6 was prepared by mixing them in (1:2:2:2:2:1) proportions. POL–6 has been standardized on the basis of organoleptic properties, physical characteristics, and physicochemical properties. The antioxidant activities were evaluated using free radical scavenging methods for 1,1–diphenyl–2–picrylhydrazyl, (DPPH) and nitric oxide assays. Anti–inflammatory activity was done by albumin denaturation and HRBC membrane stabilization assays. Cell viability assay was used for immunomodulatory activity measurement by cultivating peripheral blood mononuclear cells. Results: The results obtained from physical and chemical parameters evaluation shows that the contents of preparation present are within permissible limits . In in–vitro antioxidant studies POL–6 showed significant antioxidant activity when tested in 1–1 Diphenyl–2–picrylhydrazyl and nitric oxide assays. In in – vitro anti‐inflammatory investigation, POL–6 exhibited significant inhibition against albumin denaturation and significant protection against membrane stabilization assay. POL–6 also exhibit significant immunomodulatory activity at low doses, when tested in cell viability assay. Conclusion: The results from this study rationalize the medicinal use of POL–6 in oxidative, inflammatory and immune disorders. Keywords: Polyherbal preparation, Antioxidant, Anti‐inflammatory, Immunomodulatory
机译:目的:本研究的目的是开发和标准化多草药制剂(POL-6),并评估其在治疗氧化,炎症和免疫疾病中的用途。方法:对贯叶连翘,百古草,积雪草,Withania somnifera,圣殿和山茶干燥的植物原料分别进行水醇提取,并在(1:2:2:2:2)中混合制成POL-6。 :1)比例。 POL-6已根据感官特性,物理特性和理化特性进行了标准化。使用自由基清除方法评估抗氧化剂的活性,用于1,1–二苯基–2–甲基酰肼(DPPH)和一氧化氮测定。抗炎症活性通过白蛋白变性和HRBC膜稳定化验来完成。通过培养外周血单核细胞,将细胞活力测定用于免疫调节活性的测量。结果:通过理化参数评估获得的结果表明,制剂的含量在允许的范围内。在体外抗氧化剂研究中,POL-1在1–1二苯基–2–苄基肼基和一氧化氮测定中进行测试时显示出显着的抗氧化活性。在体外抗炎研究中,POL-6对白蛋白变性具有显着抑制作用,对膜稳定化验具有显着保护作用。在细胞活力测定中进行测试时,POL-6在低剂量时也表现出显着的免疫调节活性。结论:这项研究的结果使POL-6在氧化性,炎症性和免疫性疾病中的药用合理化。关键词:多草药制剂,抗氧化剂,抗炎,免疫调节

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号